Patient Group Direction

Advance notice

From From 01 October 2024, the national patient group directions (PDGs) for Cheshire and Merseyside will be available on the Cheshire and Merseyside ICB website.

Please bookmark the ICB PGD page now: Patient Group Directions

The PGDs will continue to be available from this legacy Pan Mersey APC website until the end of October.

Maternal Pertussis Vaccination Programme - Important Information

From 1 July 2024, ADACEL (Tdap), a non-IPV-containing vaccine, will replace Boostrix-IPV (dTaP/IPV) for the pertussis vaccination in pregnancy programme.

The ADACEL vaccine, manufactured by Sanofi, was licensed for UK use in 2016. The JCVI recognises the importance of vaccinating pregnant women to protect their babies from pertussis and the advice is clear that Boostrix-IPV vaccine should still be given if ADACEL is not available to avoid delays in vaccination.

A bipartite letter providing key information to both commissioners and healthcare professionals responsible for the delivery of the maternal pertussis vaccination programme is available here:  https://www.gov.uk/government/publications/prenatal-pertussis-vaccine-change-from-july-2024-letter